The purpose of this study was to evaluate the initiating activity of the hepatocarcinogen beta-blocker DL-1 -(2-nitro-3-methyl-phenoxy)-3-ter~-butylamino-propan-2-ol (DL-ZAMI 1305) by thc initiation-promotion protocol of Pereira. Female Wistar rats were given a single dose 150 mg/kg of body weight of DL-ZAMI 1305 by gavage 24 hours before or 24 hours after partial hepatectomy. One week later rats were given phcnobarbital(O.O5%) in the diet fora period of 7 weeks. DL-ZAMI 1305-treatment resulted in the appearance of y-glutamyltranspcptidasc foci and of other preneoplastic lesions in all animals. Prcncoplastic lesions were also present in a fraction of DL-ZAMI 1305-treated animals not subjected to partial hepatectomy, whether given or not phenobarbital. Results obtained in a separate experiment demonstrated that DL-ZAMI 1305trcatment inhibits cell proliferation and induces DNA damage in the regenerating rat liver. The results of this study clearly demonstratcd that the beta-blocker DL-ZAMI 1305 is an initiating carcinogen for the liver of female Wistar rats.
INTRODUCTION
In the last few years our laboratory has been engaged in the study oflivercarcinogenesis by DL-142nitro-3-methyl-phenoxy)-3-ferf-butylamino-propan-2-01 (DL-ZAMI 1305). The molecule, originally synthesized as a therapeutic beta-adrenoreceptor blocking agent (4) for the control of hypertension, was shown to induce the development of neoplastic nodules and of metastatic hepatocellular carcinomas in female Wistar rats after a 6-month administration (23) . Other compounds belonging to the class of beta-adrenoreceptor blocking agents have been shown also to be carcinogenic by long-term tests of carcinogenicity (1, 7, 8, 16) or to increase the tumor incidence when given in association with chemical carcinogens (2, 10). Should the oncogenic activity of these compounds be related to their pharmacologic properties rather than to the molecular structure, as suggested by some authors (9, lo) , these findings raise the question of the hazard for iatrogenic tumors.
Because of the theoretical and practical interest of the issue of a relationship between oncogenic and Presented at the Third Sardinian International Symposium, October 6-9, 1985 in Caglian, Italy. beta-blocking activity of a molecule, experiments should be carried out to test beta-blockers for initiating or promoting or co-carcinogenic activity by suitable two-stage protocols ofcarcinogenesis. Thus, we have undcrtaken a series ofexperiments designed to elucidate the mechanisms of hepatocarcinogenesis by DL-ZAMI 1305 (1 3, 14, 18-22, 24, 3 1, 32) .
Possibly consistent with its DNA damaging capacity (19) , DL-ZAMI 1305 was recently demonstrated by the Solt and Farber short-term test of hepatocarcinogenesis (27) to have initiating activity for the liver of the female Wistar rat (32) , as demonstrated by the appearance of foci of phenotypically altered hepatocytes. However, in these expcriments liver preneoplastic lesions were also found among 2-AAF-treated control rats. Thereforc, in order to obtain results not obscured by the effects of another carcinogen, the initiating capacity of DL-ZAMI 1305 was assessed by a different expcrimental model based on the employment of a non-carcinogenic promoter.
For this purpose, we adopted the initiation-promotion protocol of Pereira (17) Fig. 1 . The treatment regimen includes threc experimental (1, 2, 3) and four control groups (4, 5 , 6, 7) , each consisting of 4-12 animals. Animals of groups 1, 3, and 4 were treated by gavage with a single dose of DL-ZAMI 1305 (150 mdkg body weight) dissolved in tap water.
In experimental group 1, PH was performed 24 hours before DL-ZAMI 1305 administration according to the Pereira's protocol. A modification of the Pereira protocol, consisting of performing partial hepatectomy 14 hours after DL-ZAMI 1305 administration, was also adopted in experimental group 2 with the aim to evaluate liver DNA damage induced by DL-ZAMI 1305 treatment and to search for a quantitative correlations between the amount of DNA damage and the subsequent development of preneoplastic ylglutamyltranspeptidase foci. Animals of experimental group 3 were not subjected to PH. The animals ofthe three experimental groups and those of control groups 5 and 6 were fed the basal diet for 1 week and the basal diet added with 0.05% PB for 7 additional weeks. Control groups lacked PH (group 4) or DL-ZAMI 1305-treatment (group 5 ) or both (group 6); the animals of group 7 were left untreated. Animals were weighed every day in the first week and once a week in the following period of experimentation. All surviving animals were killed by cervical dislocation 56 days after the beginning of the experiment and liver samples were taken for histological and histochemical examination. The animals were starved 24 hours before sacrifice for the histochemical demonstration of glycogen-retaining cells. At the time of killing the animals and their livers were weighed for the determination of relative liver weight (g absolute liver weight/ 100 g body weight).
Histology. A sample of each liver lobe removed at the time ofsacrifice was fixed in Carnoy's solution and parafin sections were stained with hematoxylin-eosin (H&E) and with the periodic acid-Schiff (PAS) for glycogen. A sample of each right anterior, right posterior, and caudate lobes were also fixed in chilled acetone and paraffin embedded for the demonstration of y-glutamyltranspeptidase (GGT) activity (15) . GMNA was used as a substrate and Fast Blue BB was used as a coupling agent (25) . The number of GGT foci was counted by direct microscope observation and referred to as number of foci per cmz of section. All foci which contained 9 or more nuclei were counted. The areas examined were measured by projecting an image of the sections onto a drawing paper by a Nikon Micropan microprojector. The outlines of the sections were traced and drawings were quantified by means ofa digitizer (Bit Pad One, Summagraphics) connected to an Oli- vetti M20 computer. The total section area cxamined was between 1 and 2.8 cm2 for each animal. Liver lobes excised at the time of hepatectomy were also examined. Esalitaliori of Hepatic DNA Damage. DNA damage was evaluated by alkaline sucrose gradicnt analysis as previously described (6, 19) . DNA content in the various fractions was determined by the fluorimetric procedure of Zubroff and Sarma (33) . The quantification of DNA damage was obtained by calculating the value of the ratio DE/D, (19) , where DE and Dc are the ratios of light DNA/heavy DNA in treated and control animals, respectively. Light DNA (mol. wt. < I x lo9) and heavy DNA (mol. wt. > 1 x lo9) are the amounts of DNA in fractions 6-16 and 1-5, respectively, fraction 1 being the first to be collected from the bottom of the ccntrifuge tube. DNA damage was evaluated on thc excised liver lobes of all thc animals of experimental group 2 and in the regenerating liver of 4 animals of group 1, which were killed 38 hours after partial hepatectomy, and 14 hours aftcr administration of DL-ZAMI 1305 when DNA damage in intact animals is maximal (1 9). Controls were 2 animals of group 5 hepatectomized 38 hours before the sacrifice.
Mitoses Coirrit. The influence of DL-ZAMI 1305 administration on the mitotic activity of hepatocytes was assessed in thc regenerating liver of the animals of groups 1 and 5 which were killed for the evaluation of DNA damage. Mitoses were counted in 50 microscopic fields, each of 0.04 mm2, of both the right anterior and right posterior lobes.
Slalisrical Analysis. The data are the mean -t-SEM. The significance of the difference of the means is evaluated by the analysis of variance and by the randomization test (26).
RESULTS
Hepatectomy caused the death of almost all the animals receiving DL-ZAMI 1305 14 hours before surgery (group 2): only onc out of 12 rats survived, while the others died within 3 days after hcpatectomy. There was mortality also in the other groups but no differences were observed among control and experimental groups (Table I) . After the first wcek, during which a reduction of body weight was observed in the animals subjected to PH and/or to 
PACCES ET AL TOXICOLOGIC PATHOLOGY
DL-ZAMI 1305 treatment, average body weight gain was the same in all experimental and control groups throughout the following 7 weeks of experimentation. Absolute and relative liver weights were higher in the PB-treated animals whether or not they were subjected to PH when compared to those of the animals fed the basal diet. GGT foci were detected in all animals of the experimental groups 1 and 2 and in a fraction of the animals of experimental group 3 not subjected to PH (Table I) . Hepatectomy increased the number of GGT foci; this was most evident when the right posterior lobe was considered (Table 11 ). GGT foci were occasionally detected also in control groups 4, 5, and 6. No foci were present in untreated control animals (group 7). Oval cell hyperplasia, generally mild, a few eosinophilic, basophilic, and clear cell foci were present in almost all the animals of the experimental groups and of the control group 4. Colangiofibrosis, associated with a prominent oval cell hyperplasia, was also observed in two animals of groups 1 and 3 (Table I, Fig. 2A-D) . Often the presence of GGT foci coincided with the presence of foci of eosinophilic cells, showing voluminous nuclei and prominent nucleoli, evidenced by H&E staining of adjacent sections. Apart from GGT foci, no other preneoplastic lesions were detected in animals of control groups 5, 6, and 7 not receiving When DNA damage induced by DL-ZAMI 1305 in regenerating rat liver was studied (group 1) the mean value ofthc damage was lowcr(DE/D, = 1.62) than that found in the excised liver lobes ofthc intact animals of group 2 subjected to PH after DL-ZAMI 1305 administration (DE/Dc = 2.64), but the difference was not significant. The high mortality of the animals of group 2 hampered the possibility to correlate the amount of DNA damage with the frequency of GGT foci. In the single animal of this group that survived until the end ofexperimentation the amount of DNA damage was 2.27 and the frequency of GGT foci was 6.1/cm2. A significant inhibition ofPH-induced hepatocyte proliferation was observed in DL-ZAMI 1305-treated (group 1) with respect to untreated rats (group 5); the mean number of mitoses per mm2 was 20 and 67, respectively, in the right anterior lobe and 15 and 47 in the right posterior lobe. No relationship appeared to exist between the amount ofDNA damage and the number of hepatocytes in mitosis.
DL-ZAMI 1305.
DISCUSSION
To gain insight into the mechanism of hepatocarcinogenesis by the beta-blocker DL-ZAMI 1305, a series of experiments specifically designed to eval-uate the initiating and/or promoting activity of this molecule are being camed out in our laboratory.
Using the short-term test of hcpatocarcinogenesis developed by Soh and Farbcr to detect initiating carcinogens (27) , we recently demonstrated that 1 week ip treatment with DL-ZAMI 1305 induces the appearance of preneoplastic lesions-oval cell hyperplasia, basophilic, and GGT foci-in the liver of female Wistar rats (32) . The present report confirms the initiating capacity of DL-ZAMI 1305. Enzymealtered foci were induced in the liver of the female Wistar rat by a single gavage administration of DL-ZAMI 1305 at 150 mg/kg body weight followed by a 7-week period of promotion with phenobarbital. The frequency of GGT foci was of the same order of magnitude as that reported by Herren et al (1 1) for other well-known chemical carcinogens tested by the same experimental protocol (17) . Other preneoplastic lesions, eosinophilic and basophilic foci, clear cell foci, oval cell hyperplasia, and colangiofibrosis, were also found in rats initiated by DL-ZAMI 1305, even among those not subjected to PH.
Partial hepatectomy, performed either before or after initiation, enhanced the appearance of GGT foci suggesting that cell proliferation, as reported for a number ofother chemical carcinogens (3,5), plays an important role in the initiation of liver carcinogenesis by DL-ZAMI 1305. It is worth noting that GGT foci and other preneoplastic lesions were also present in the livers of animals not subjected to PH and even among control rats treated with DL-ZAMI 1305 only (group 4), whereas no preneoplastic lesions, apart from GGT foci, were present in the other control groups. It then appears that a single administration of DL-ZAMI 1305 alone is sufficient to initiate neoplastic transformation of liver. Relevant to this point may be the fact that the dose of DL-ZAMI 1305 used exerted a slight hepatotoxic effect, as documented by the finding of a few scattered necrotic hepatocytes in the liver lobes excised from the animals subjected to PH 24 hours after DL-ZAMI 1305 administration. The regeneration subsequent to liver cell necrosis may explain the development of prcneoplastic lesions in the absence of surgical hepatectomy (30) .
One of the aims of this study was to search for a correlation between the amount of DNA damage induced by DL-ZAMI 1305 and its initiating activity as quantified by the frequency of GGT foci detected in the same animal. Unfortunately, almost all animals subjected to PH after DL-ZAMI 1305 treatment died in the very first days of experimentation, thus hampering any conclusion. The amount of DNA damage induced by DL-ZAMI 1305 in regenerating liver was not significantly different from that found in the liver of intact animals (group 1 versus group 2). In regenerating liver, DL-ZAMI 1305 treatment resulted also in significant inhibition of cell proliferation as previously observed in the liver of intact animals (22) .
The results of this study demonstrate that DL-ZAMI 1305 shares common properties with well-known initiating carcinogens in that a single treatment with this molecule causes DNA damage, inhibits cell proliferation and, when a promoting stimulus follows the administration of the compound, induces the development of GGT foci and of other liver preneoplastic lesions. It is therefore possible to conclude that this beta-blocker is an initiating carcinogen in female Wistar rat liver.
Studies in vifro demonstrated that non-toxic concentrations ofDL-ZAMI 1305 decreased the growth rate and inhibited the capacity to intercommunicate of CH V79 cells in a dose-dependent fashion (14) . The capacity of a molecule to inhibit cell communication is considered an indicator of its tumorpromoting ability (28, 29) . Preliminary results of in v i w experiments performed to assess the promoting activity of DL-ZAMI 1305 in male rat liver initiated by a single administration of DENA suggest that DL-ZAMI 1305 is effective in promoting the development of GGT foci and of neoplastic nodules.
Experiments are now being planned to investigate whether the pharmacologic activity of DL-ZAMI 1305 is relevant to its initiating andlor promoting activity.
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